IL104828A - Synthesis of alpha-converted arylacetamides and alpha-converted arylethylamines and some 2,3,4,5 tetrahydro- H3-1 new benzazepines - Google Patents

Synthesis of alpha-converted arylacetamides and alpha-converted arylethylamines and some 2,3,4,5 tetrahydro- H3-1 new benzazepines

Info

Publication number
IL104828A
IL104828A IL10482893A IL10482893A IL104828A IL 104828 A IL104828 A IL 104828A IL 10482893 A IL10482893 A IL 10482893A IL 10482893 A IL10482893 A IL 10482893A IL 104828 A IL104828 A IL 104828A
Authority
IL
Israel
Prior art keywords
tetrahydro
methyl
group
hydroxy
chloro
Prior art date
Application number
IL10482893A
Other languages
English (en)
Hebrew (he)
Other versions
IL104828A0 (en
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of IL104828A0 publication Critical patent/IL104828A0/xx
Publication of IL104828A publication Critical patent/IL104828A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/16—Benzazepines; Hydrogenated benzazepines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Veterinary Medicine (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
IL10482893A 1992-02-25 1993-02-23 Synthesis of alpha-converted arylacetamides and alpha-converted arylethylamines and some 2,3,4,5 tetrahydro- H3-1 new benzazepines IL104828A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/841,603 US5241065A (en) 1992-02-25 1992-02-25 2,3,4,5-tetrahydro-1h-3-benzazepines having anti-psychotic activity

Publications (2)

Publication Number Publication Date
IL104828A0 IL104828A0 (en) 1993-06-10
IL104828A true IL104828A (en) 1999-08-17

Family

ID=25285279

Family Applications (1)

Application Number Title Priority Date Filing Date
IL10482893A IL104828A (en) 1992-02-25 1993-02-23 Synthesis of alpha-converted arylacetamides and alpha-converted arylethylamines and some 2,3,4,5 tetrahydro- H3-1 new benzazepines

Country Status (12)

Country Link
US (2) US5241065A (de)
EP (1) EP0628030B1 (de)
JP (1) JPH07504196A (de)
AT (1) ATE229510T1 (de)
AU (1) AU3722193A (de)
CA (1) CA2130797C (de)
DE (1) DE69332559T2 (de)
ES (1) ES2183810T3 (de)
IL (1) IL104828A (de)
TW (1) TW241260B (de)
WO (1) WO1993016997A1 (de)
ZA (1) ZA931261B (de)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5939412A (en) * 1992-06-26 1999-08-17 Smithkline Beecham Corporation Bicyclic fibrinogen antagonists
US5693636A (en) * 1991-06-28 1997-12-02 Smithkline Beecham Corporation Bicyclic fibrinogen antagonists
MA23420A1 (fr) * 1994-01-07 1995-10-01 Smithkline Beecham Corp Antagonistes bicycliques de fibrinogene.
US6458784B1 (en) 1994-06-29 2002-10-01 Smithkline Beecham Corporation Vitronectin receptor antagonists
US5977101A (en) * 1995-06-29 1999-11-02 Smithkline Beecham Corporation Benzimidazoles/Imidazoles Linked to a Fibrinogen Receptor Antagonist Template Having Vitronectin Receptor Antagonist Activity
US6867310B1 (en) 1997-11-20 2005-03-15 Massachusetts Institute Of Technology Arylation and vinylation of activated carbons
ES2209728T3 (es) * 1999-08-06 2004-07-01 F. Hoffmann-La Roche Ag Tetrahidro-benzo(d)azepinas y su uso como antagonistas de receptores de glutamato metabotropico.
EP1274744A2 (de) 2000-04-13 2003-01-15 E.I. DUPONT DE NEMOURS AND COMPANY, Legal Patent Records Center Polymerträger-herstellungsverfahren von heteroatom-bidentatliganden und verwendung zur katalyse
KR100897642B1 (ko) 2002-12-20 2009-05-14 글락소 그룹 리미티드 신경 장애 치료용 벤즈아제핀 유도체
PL2332921T3 (pl) 2003-06-17 2016-08-31 Arena Pharm Inc Chlorowodorek 8-chloro-1-metylo-2,3,4,5-tetrahydro-1H-3-benzazepiny
NZ552397A (en) 2004-07-15 2011-04-29 Amr Technology Inc Aryl-and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin
ES2600460T3 (es) 2005-05-10 2017-02-09 Intermune, Inc. Derivados de piridona-2-ona como moduladores del sistema de proteína cinasa activada por estrés
EP2001852A2 (de) 2006-04-03 2008-12-17 Arena Pharmaceuticals, Inc. Verfahren zur herstellung von 8-chlor-1-methyl-2,3,4,5-tetrahydro-1h-3-benzazepin und entsprechenden zwischenprodukten
CN101547892B (zh) 2006-12-05 2014-08-20 艾尼纳制药公司 制备(r)-8-氯-1-甲基-2,3,4,5-四氢-1h-3-苯并氮杂卓的方法和其中间体
EP2288585A1 (de) 2008-03-04 2011-03-02 Arena Pharmaceuticals, Inc. Verfahren zur herstellung von mit dem 5-ht2c-agonisten (r)-8-chlor-1-methyl-2,3,4,5-tetrahydro-1h-3-benzazepin verwandten zwischenprodukten
CN102099036B (zh) 2008-06-03 2015-05-27 英特芒尼公司 用于治疗炎性疾患和纤维化疾患的化合物和方法
US9156812B2 (en) 2008-06-04 2015-10-13 Bristol-Myers Squibb Company Crystalline form of 6-[(4S)-2-methyl-4-(2-naphthyl)-1,2,3,4-tetrahydroisoquinolin-7-yl]pyridazin-3-amine
AU2010247735B2 (en) 2009-05-12 2015-07-16 Albany Molecular Research, Inc. Crystalline forms of (S)-7-([1,2,4]triazolo[1,5-a]pyridin-6-yl)-4-(3,4-dichlorophenyl)- 1,2,3,4-tetrahydroisoquinoline and use thereof
AU2010247763B2 (en) * 2009-05-12 2015-12-24 Albany Molecular Research, Inc. 7-([1,2,4,]triazolo[1,5,-a]pyridin-6-yl)-4-(3,4-dichlorophenyl)-1,2,3,4- tetrahydroisoquinoline and use thereof
WO2010132437A1 (en) 2009-05-12 2010-11-18 Albany Molecular Research, Inc. Aryl, heteroaryl, and heterocycle substituted tetrahydroisoquinolines and use thereof
US8952197B2 (en) 2009-06-18 2015-02-10 Arena Pharmaceuticals, Inc. Processes for the preparation of 5-HT2C receptor agonists
US9045431B2 (en) 2010-06-02 2015-06-02 Arena Pharmaceuticals, Inc. Processes for the preparation of 5-HT2C receptor agonists
JP6272695B2 (ja) 2010-09-01 2018-01-31 エーザイ・アール・アンド・ディー・マネジメント株式会社 体重管理のために有用な５−ｈｔ２ｃアゴニストの改変放出剤形
AU2011296015B2 (en) 2010-09-01 2015-11-12 Arena Pharmaceuticals, Inc. Administration of lorcaserin to individuals with renal impairment
JP2013536859A (ja) 2010-09-01 2013-09-26 アリーナ ファーマシューティカルズ， インコーポレイテッド ５−ｈｔ２ｃアゴニストの非吸湿性塩
KR20130138770A (ko) 2010-09-01 2013-12-19 아레나 파마슈티칼스, 인크. 광학적으로 활성 산을 갖는 로르카세린의 염
AR092742A1 (es) 2012-10-02 2015-04-29 Intermune Inc Piridinonas antifibroticas
JP2015534563A (ja) 2012-10-09 2015-12-03 アリーナ ファーマシューティカルズ， インコーポレイテッド 体重管理の方法
MX382781B (es) 2014-04-02 2025-03-13 Intermune Inc Piridinonas anti-fibroticas.
WO2021213353A1 (zh) * 2020-04-20 2021-10-28 苏州恩华生物医药科技有限公司 酰胺或者磺酰胺类衍生物及其应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA882080B (en) * 1987-03-27 1989-04-26 Schering Corp Substituted benzazepines,their preparation and pharmaceutical compositions containing them
US5015639A (en) * 1987-03-27 1991-05-14 Schering Corporation Substituted benzazepines, their preparation and pharmaceutical compositions containing them
DE3936594A1 (de) * 1989-09-15 1991-03-28 Basf Ag (gamma)-glutamyl-transferasen zur behandlung von krankheiten
AU8201591A (en) * 1990-06-15 1992-01-07 Schering Corporation 8-lower alkyl-5-cycloalkyl or 5-cycloalkenyl substitued benzazepines and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
WO1993016997A1 (en) 1993-09-02
DE69332559T2 (de) 2003-11-20
EP0628030A1 (de) 1994-12-14
IL104828A0 (en) 1993-06-10
CA2130797A1 (en) 1993-08-26
ZA931261B (en) 1993-08-23
ES2183810T3 (es) 2003-04-01
ATE229510T1 (de) 2002-12-15
TW241260B (de) 1995-02-21
JPH07504196A (ja) 1995-05-11
AU3722193A (en) 1993-09-13
EP0628030B1 (de) 2002-12-11
US5530125A (en) 1996-06-25
US5241065A (en) 1993-08-31
DE69332559D1 (de) 2003-01-23
CA2130797C (en) 2006-07-04

Similar Documents

Publication Publication Date Title
EP0628030B1 (de) 2,3,4,5-tetrahydro-1h-3-benzazepinen mit anti-psychotisch wirkung, und synthese von alfa-substituierten-arylacetamiden
US5296482A (en) (Benzocycloalkyl) alkylamines
US9403776B2 (en) Aryl- and heteroaryl-substituted tetrahydrobenzazepines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin
JPH08501559A (ja) セロトニン受容体剤
JP4748320B2 (ja) 環状アミン誘導体又はその塩
IE912031A1 (en) 8-lower alkyl-5-cycloalkyl or 5-cycloalkenyl substituted¹benzazepines and pharmaceutical compositions containing them
CA1333485C (en) Fused benzazepines
JPH03120218A (ja) 痛みおよび／または中枢神経系障害の新規治療用医薬およびそれに用いる複素環式化合物
IE58883B1 (en) Nitrogen containing compounds
BE898072A (fr) Derives du pyrrole et leur preparation.
WO2014063587A1 (zh) 一类氟取代的环状胺类化合物及其制备方法、药物组合物和用途
EP1680127B1 (de) Benzazepin-derivate als mao-b-hemmer
US5258384A (en) S-11-hydroxy-10-methylaporphine and its biologically active salt forms as 5HT1A inhibitors
JP2002537288A (ja) ドーパミンｄ１受容体アゴニスト化合物
KR20010072262A (ko) 삼환식 카르복스아미드
EP0299101A1 (de) Kondensierte Benzazepine
AU760373B2 (en) New spiro imidazoline compounds, a process for their preparation and pharmaceutical compositions containing them
JPH09216879A (ja) （１ｈ−インドール−４−イル）−ピペリジンまたはテトラヒドロピリジンのエチルアミンおよびエチルカルボキサミド
JP2928307B2 (ja) ピロリジン誘導体
JP2853404B2 (ja) 抗不整脈薬
JPH11349481A (ja) シグマ受容体結合剤
ITMI961861A1 (it) Derivati tetraciclici spiro-condensati

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees